Sign in

CIK 0001549595

  • Large accelerated filer

Nurix Therapeutics, Inc.

Sign in to watch
Ticker
NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Nov 30
Incorporated
DE
Entity type
Operating
EIN
270838048
Phone
+1 415-660-5320
Business address
1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
Former names
Nurix, Inc.
  1. 4 Open-market sale Chief Legal Officer sold 1,513 shares at $12.04 ($18,220)
  2. 4 Planned sale Chief Financial Officer sold 6,812 shares at $10.02 ($68,223)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market sale Chief Financial Officer sold 1,671 shares at $7.99 ($13,352)
  8. 4 Open-market sale Chief Scientific Officer sold 2,334 shares at $7.99 ($18,649)
  9. 4 Open-market sale Chief Legal Officer sold 1,760 shares at $7.99 ($14,063)
  10. 4 Planned sale Chief Financial Officer sold 3,541 shares at $10.00 ($35,421)
  11. 4 Planned sale Chief Financial Officer sold 10,906 shares at $10.00 ($109,093)
  12. 4 Open-market sale Chief Financial Officer sold 1,080 shares at $5.20 ($5,613)
  13. 4 Open-market sale Chief Legal Officer sold 1,232 shares at $5.20 ($6,403)
  14. 4 Open-market sale Chief Scientific Officer sold 1,633 shares at $5.20 ($8,487)
  15. 4 Open-market sale Chief Financial Officer sold 1,245 shares at $9.65 ($12,020)
  16. 4 Open-market sale General Counsel sold 1,420 shares at $9.65 ($13,710)
  17. 4 Open-market sale Chief Scientific Officer sold 1,884 shares at $9.65 ($18,189)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 7 of 14 · 274 filings